IV vancomycin-oral ciprofloxacin: A safe and efficient therapeutic protocol for CAPD peritonitis (preliminary report)

Peritoneal Dialysis International

Volumn 16, Issue 2, 1996, Pages 174-177

  Goffin, Eric ^a   Pouthier, Dominique ^b   Vandercam, Bernard ^a   Gigi, Jacques ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PERITONITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030023633     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600216     Document Type: Article

References (18)

1. Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11:252-60.
2. Saklayen MG. CAPD peritonitis. Incidence, pathogens, diagnosis and management. Med Clin North Am 1990; 74:997-1010.
3. Williams JD, Coles GA. CAPD peritonitis. Int J Antimicrob Agents 1992; 1:165-74.
4. Bailie GR, Eisele G. Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy. Ann Pharmacother 1992; 26:1409-20.
5. Keane WF, Everett ED, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations. Perit Dial Int 1993; 13:14-28.
6. Neville LO, Baillod RA, Brumfitt W, Hamilton-Miller JMT. Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis. J Antimicrob Chemother 1988; 21:5123-31.
7. Freiman JP, Graham DJ, Greene Reed T, McGoodwin EB. Chemical peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 1992; 12:57-60.
8. Obermiller LE, Tzamaloukas AH, Leymon P, Avasthi PS. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis. Clin Nephrol 1985; 24:256-60.
9. Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31:173-7.
10. Hooper DC. Quinolones. In: Mandell GL, Benett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:364-76.
11. Mulhern JG, Braden GL, O'Shea MH, Madden RL, Lipkowitz GS, Germain MJ. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25:611-15.
12. Waite NM, Johnson MD, Webster NR, Fong IW. Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. Perit Dial Int 1993; 13:50-4.
13. Fleming LW, Phillips G, Stewart WK, Scott AC. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25:441-8.
14. Barretti P, Bignardi JH, Soares VA. Successful treatment of peritonitis in IPD with oral fluoroquinolone. Perit Dial Int 1993; 13:192.
15. Hancock K, Hulme B. Treatment of CAPD peritonitis with oral ciprofloxacin.Nephrol Dial Transplant 1989; 8:759.
16. Nye KJ, Gibson SP, Nwosu AC, et al. Single dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report. Perit Dial Int 1993; 13:59-60.
17. Neu HC. Synergy of fluoroquinolones with other anti-microbial agents. Rev Infect Dis 1989; 11:1-11.
18. Shalit I. Immunological aspects of new quinolones. Eur J Clin Microbiol Infect Dis 1991; 10:262-6.